Population
194 adults including 36 healthy subjects, 23 hypopituitary patients untreated with GH, 43 acromegalics, 42…
Design
Cross-sectional
Authors
Loading...
May support IGFBP-3 proteolysis in insulin deficiency adaptation; leaves open its role in GH secretion disorders.
Regulation of IGF-I bioavailability by limited proteolysis of IGFBP-3 contributes to adaptation to insulin deficiency and/or resistance, but not to disturbances of GH secretion.
Lassarre et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: